Vivo Capital, LLC Portfolio Holdings

Vivo Capital, LLC

  • $472 Million
  • Q2 2025

Vivo Capital, LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $472 Million distributed in 42 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $132M, Geron Corp with a value of $38.4M, Oric Pharmaceuticals, Inc. with a value of $31.7M, Compass Pathways PLC with a value of $28.7M, and Terns Pharmaceuticals, Inc. with a value of $25.7M.

Examining the 13F form we can see an increase of $104M in the current position value, from $368M to 472M.

Vivo Capital, LLC is based out at Palo Alto, CA

Below you can find more details about Vivo Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $472 Million
Healthcare: $472 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 42
  • Current Value $472 Million
  • Prior Value $368 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 7 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email